Beyond Air Inc is a medical technology company focused on developing innovative therapies for respiratory diseases
The company harnesses the power of nitric oxide, a naturally occurring gas, to create non-invasive treatments aimed at improving lung function and overall patient health. By leveraging its proprietary nitric oxide delivery system, Beyond Air seeks to address significant unmet medical needs in patients suffering from conditions such as asthma and other chronic respiratory ailments. Their commitment to advancing respiratory care aims to enhance the quality of life for patients while promoting safety and efficacy in treatment options.
Companies Reporting Before The Bell • Beasley Broadcast Group (NASDAQBBGI) is projected to report quarterly loss at $0.07 per share on revenue of $66.05 million.
Beyond Cancer Ltd, an affiliate of Beyond Air Inc (NASDAQXAIR), announced that the Phase 1 Study evaluating ultra-high concentration nitric oxide (UNO) in advanced, relapsed or refractory unresectable, primary or metastatic cutaneous and subcutaneous solid tumors has cleared the
